Interestingly, PGT-M is less commonly used for genes associated with Lynch syndrome compared to the breast cancer susceptibility genes BRCA1/2, even though both conditions have similar prevalence and severity [95]. This evidence concerns the gene BRCA1 and Lynch syndrome.